Abstract In patients with metabolic dysfunction-associated steatotic liver disease, two serum fibrosis panels with patented algorithms are among the most cited: the Nash-FibroTest combination (FibroTest), which assesses fibrosis, steatosis and inflammatory activity in one sample, and the Enhanced Liver Fibrosis (ELF) score, which evaluates fibrosis alone. No head-to-head one-step comparison has been published in type-2 diabetes.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Antoine
Contact Antoine, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack